Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2002 1
2004 1
2005 2
2006 3
2007 1
2008 1
2010 4
2011 8
2012 1
2013 4
2014 2
2015 1
2016 3
2017 1
2020 1
2021 1
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
UDP-glucose, cereblon-dependent proinsulin degrader.
Cho J, Miyagawa A, Yamaguchi K, Abe W, Tsugawa Y, Yamamura H, Imai T. Cho J, et al. Among authors: abe w. Sci Rep. 2022 Aug 26;12(1):14568. doi: 10.1038/s41598-022-18902-5. Sci Rep. 2022. PMID: 36028536 Free PMC article.
UDP-Glucose: A Cereblon-Dependent Glucokinase Protein Degrader.
Cho J, Miyagawa A, Yamaguchi K, Abe W, Tsugawa Y, Yamamura H, Imai T. Cho J, et al. Among authors: abe w. Int J Mol Sci. 2022 Aug 13;23(16):9094. doi: 10.3390/ijms23169094. Int J Mol Sci. 2022. PMID: 36012359 Free PMC article.
Aberrant histone modification in endometriosis.
Nasu K, Kawano Y, Kai K, Aoyagi Y, Abe W, Okamoto M, Narahara H. Nasu K, et al. Among authors: abe w. Front Biosci (Landmark Ed). 2014 Jun 1;19(8):1202-14. doi: 10.2741/4276. Front Biosci (Landmark Ed). 2014. PMID: 24896345 Free article. Review.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group. Montgomery H, et al. Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7. Lancet Respir Med. 2022. PMID: 35688164 Free PMC article. Clinical Trial.
Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.
Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K. Suzuki Y, et al. Among authors: abe w. Clin Exp Med. 2023 Oct;23(6):2715-2723. doi: 10.1007/s10238-022-00949-3. Epub 2022 Dec 5. Clin Exp Med. 2023. PMID: 36469171 Free PMC article.
Start and initial results of the Fukushima Prefecture acute myocardial infarction registration survey.
Nakazato K, Yamaki T, Kijima M, Komatsu N, Sugi M, Seita H, Kanke M, Saito T, Owada T, Ono M, Kanazawa M, Abe Y, Sato M, Watanabe M, Suzuki S, Tsuda A, Chiba K, Honda T, Tamagawa K, Watanabe T, Abe W, Maeyama T, Sagawa K, Takahira H, Sodenaga Y, Ohara N, Kobayashi T, Hisa S, Suzuki S, Saito Y, Shineha R, Suzuki F, Matsui J, Tsuboi M, Yui T, Abe S, Nagasawa S, Takaya Y, Maehara K, Maruyama Y, Takeishi Y; Fukushima Prefecture AMI Registration Survey Investigators. Nakazato K, et al. Among authors: abe w. Fukushima J Med Sci. 2013;59(1):27-34. doi: 10.5387/fms.59.27. Fukushima J Med Sci. 2013. PMID: 23842511 Free article.
33 results